| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |